Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-07-02 5:23 pm Purchase | 2024-11-04 | 13D | BRIGHT MINDS BIOSCIENCES INC C DRUG | Ian McDonald | 1,396,665 13.700% | 31,765![]() (+2.33%) | Filing History |
| 2026-05-15 5:02 pm Purchase | 2026-03-31 | 13G | BRIGHT MINDS BIOSCIENCES INC C DRUG | Vestal Point Capital, LP | 492,319 5.000% | 492,319![]() (New Position) | Filing History |
| 2026-05-15 12:36 pm Unchanged | 2026-03-31 | 13G | BRIGHT MINDS BIOSCIENCES INC C DRUG | JANUS HENDERSON GROUP Ltd. JHG | 1,284,324 13.100% | 0 (Unchanged) | Filing History |
| 2026-05-15 12:36 pm Purchase | 2026-03-31 | 13G | BRIGHT MINDS BIOSCIENCES INC C DRUG | JANUS HENDERSON GROUP Ltd. JHG | 1,284,324 13.100% | 128,329![]() (+11.10%) | Filing History |
| 2026-05-12 9:44 pm Purchase | 2026-03-31 | 13G | BRIGHT MINDS BIOSCIENCES INC C DRUG | Vivo Opportunity Fund Holdings, L.P. | 504,645 5.200% | 50,461![]() (+11.11%) | Filing History |
| 2026-04-30 4:08 pm Sale | 2026-04-28 | 13G | BRIGHT MINDS BIOSCIENCES INC C DRUG | Cormorant Asset Management LP | 950,000 9.710% | -109,331![]() (-10.32%) | Filing History |
| 2026-02-17 4:33 pm Purchase | 2025-12-31 | 13G | BRIGHT MINDS BIOSCIENCES INC C DRUG | JANUS HENDERSON GROUP Ltd. JHG | 1,155,995 14.900% | 10,335![]() (+0.90%) | Filing History |
| 2026-02-17 4:22 pm Sale | 2025-12-31 | 13G | BRIGHT MINDS BIOSCIENCES INC C DRUG | Commodore Capital LP | 18,851 0.300% | -332,997![]() (-94.64%) | Filing History |
| 2026-02-17 4:00 pm Purchase | 2025-12-31 | 13G | BRIGHT MINDS BIOSCIENCES INC C DRUG | Perceptive Advisors LLC | 449,290 4.600% | 4,641![]() (+1.04%) | Filing History |
| 2026-02-06 3:00 pm Unchanged | 2026-01-31 | 13G | BRIGHT MINDS BIOSCIENCES INC C DRUG | Cormorant Asset Management LP | 1,059,331 10.880% | 0 (Unchanged) | Filing History |
| 2025-11-14 6:38 pm Purchase | 2025-09-30 | 13G | BRIGHT MINDS BIOSCIENCES INC C DRUG | Vivo Opportunity Fund Holdings, L.P. | 454,184 6.400% | 454,184![]() (New Position) | Filing History |
| 2025-11-13 09:00 am Purchase | 2025-09-30 | 13G | BRIGHT MINDS BIOSCIENCES INC C DRUG | Adage Capital Management, L.P. | 395,743 5.580% | 395,743![]() (New Position) | Filing History |
| 2025-11-12 08:00 am Sale | 2025-09-30 | 13G | BRIGHT MINDS BIOSCIENCES INC C DRUG | Sio Capital Management, LLC | 190,764 2.690% | -321,574![]() (-62.77%) | Filing History |
| 2025-08-14 10:58 am Purchase | 2025-06-30 | 13G | BRIGHT MINDS BIOSCIENCES INC C DRUG | JANUS HENDERSON GROUP Ltd. JHG | 1,145,660 16.300% | 34,292![]() (+3.09%) | Filing History |
| 2025-08-13 2:00 pm Purchase | 2025-06-30 | 13G | BRIGHT MINDS BIOSCIENCES INC C DRUG | Sio Capital Management, LLC | 512,338 7.270% | 4,776![]() (+0.94%) | Filing History |
| 2025-05-15 4:51 pm Sale | 2025-03-31 | 13G | BRIGHT MINDS BIOSCIENCES INC C DRUG | RA Capital Management, L.P. | 206,427 2.900% | -254,402![]() (-55.21%) | Filing History |
| 2025-05-15 4:30 pm Purchase | 2025-03-31 | 13G | BRIGHT MINDS BIOSCIENCES INC C DRUG | Perceptive Advisors LLC | 444,649 6.300% | 14,649![]() (+3.41%) | Filing History |
| 2025-04-08 3:14 pm Purchase | 2025-03-31 | 13G | BRIGHT MINDS BIOSCIENCES INC C DRUG | Sio Capital Management, LLC | 507,562 7.210% | 55,769![]() (+12.34%) | Filing History |
| 2025-04-07 4:07 pm Purchase | 2025-03-31 | 13G | BRIGHT MINDS BIOSCIENCES INC C DRUG | JANUS HENDERSON GROUP Ltd. JHG | 1,111,368 16.000% | 306,392![]() (+38.06%) | Filing History |
| 2025-02-14 4:06 pm Sale | 2024-12-31 | 13G | BRIGHT MINDS BIOSCIENCES INC C DRUG | Point72 Asset Management, L.P. | 135,189 3.000% | -299,811![]() (-68.92%) | Filing History |

